Literature DB >> 25035774

Relationship of PCNA, C-erbB2 and CD44s expression with tumor grade and stage in urothelial carcinomas of the bladder.

Ayhan Yıldırım1, Mustafa Kösem2, Ilyas Sayar3, Ibrahim Gelincik4, Alparslan Yavuz5, Aliseydi Bozkurt6, Unal Erkorkmaz7, Irfan Bayram8.   

Abstract

In the present study, the intention was to reveal the relationship of histological grade and stage with c-erbB2, CD44s, and PCNA immunoreactivity in bladder urothelial carcinomas (UC). In our study, we evaluated 46 items of transurethral resection material of patients submitted by YYU Faculty of Medicine, Main Department of Pathology, with a mass revealed in their bladder after clinical and radiological studies at our laboratories and who were diagnosed with urothelial carcinomas. PCNA, c-erbB2, and CD44s were applied in an immunohistochemical manner comprised from nine low-malignant potential papillary urothelial neoplasia, 23 low-grade papillary urothelial carcinoma, and 14 high-grade papillary urothelial carcinoma. Immunostaining was scored according to the percentage of positive cells. The immunohistochemical study demonstrated that the c-erbB2 and PCNA staining ratio increased when an increase occurred in stage and grade. The CD44s staining ratio decreased. C-erbB2, PCNA, and CD44s appear to be a useful marker in the assessment of the prognosis and treatment options in urothelial carcinomas.

Entities:  

Keywords:  C-erbB2; CD44; PCNA; Urothelial carcinomas; immunohistochemical study

Year:  2014        PMID: 25035774      PMCID: PMC4100960     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  30 in total

1.  Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems.

Authors:  J W A Oosterhuis; R F M Schapers; M L G Janssen-Heijnen; R P E Pauwels; D W Newling; F ten Kate
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

Review 2.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.

Authors:  J I Epstein; M B Amin; V R Reuter; F K Mostofi
Journal:  Am J Surg Pathol       Date:  1998-12       Impact factor: 6.394

3.  The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity.

Authors:  T Akiyama; C Sudo; H Ogawara; K Toyoshima; T Yamamoto
Journal:  Science       Date:  1986-06-27       Impact factor: 47.728

4.  Progressive loss of CD44 gene expression in invasive bladder cancer.

Authors:  T Sugino; H Gorham; K Yoshida; J Bolodeoku; V Nargund; D Cranston; S Goodison; D Tarin
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

5.  HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3).

Authors:  Luca Bongiovanni; Vincenzo Arena; Fabio Maria Vecchio; Marco Racioppi; Pierfrancesco Bassi; Francesco Pierconti
Journal:  Arch Ital Urol Androl       Date:  2013-06-24

6.  Late recurrence and progression after a long tumor-free period in primary Ta and T1 bladder cancer.

Authors:  Y Fujii; I Fukui; K Kihara; T Tsujii; Y Kageyama; H Oshima
Journal:  Eur Urol       Date:  1999-10       Impact factor: 20.096

Review 7.  The role of the CD44/ezrin complex in cancer metastasis.

Authors:  Tracey A Martin; Gregory Harrison; Robert E Mansel; Wen G Jiang
Journal:  Crit Rev Oncol Hematol       Date:  2003-05       Impact factor: 6.312

8.  Expression of the cyclin-dependent kinase inhibitor p27 in transitional cell bladder cancers: is it a good predictor for tumor behavior?

Authors:  Latife Doganay; Semsi Altaner; Selcuk Bilgi; Esat Kaya; Galip Ekuklu; Kemal Kutlu
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

9.  c-erb B-2 expression is associated with tumor location and venous invasion and influences survival of patients with gastric carcinoma.

Authors:  João Pinto-de-Sousa; Leonor David; Raquel Almeida; Dina Leitão; John R Preto; Mário Seixas; Amadeu Pimenta
Journal:  Int J Surg Pathol       Date:  2002-10       Impact factor: 1.271

10.  Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis.

Authors:  P L Nguyen; P E Swanson; W Jaszcz; D M Aeppli; G Zhang; T P Singleton; S Ward; D Dykoski; J Harvey; G A Niehans
Journal:  Am J Clin Pathol       Date:  1994-02       Impact factor: 2.493

View more
  1 in total

1.  Study of Proliferating cell nuclear antigen expression and Angiogenesis in Urothelial neoplasms: Correlation with tumor grade and stage.

Authors:  Poojan Agarwal; Achin Kumar Sen; Minakshi Bhardwaj; Veronique Dinand; Arvind Ahuja; Rajeev Sood
Journal:  Urol Ann       Date:  2018 Apr-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.